SEC Form 4 · accession 0001562180-18-003795
Akebia Therapeutics, Inc. · AKBA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Cynthia Smith
Director
Period of report
Aug 28, 2018
Accepted (ET)
Aug 29, 2018 · 4:02 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001517022
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to buy)F1 | $8.25 | Aug 28, 2018 | A | 25,000 | A | — | Aug 28, 2028 | Common Stock | 25,000 | 25,000 | D |
Explanation of responses
- F125% of this option will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter.